INTEGRATED BIOPHARMA INC INB Cash Flow

Integrated biopharma inc (INB)

CashFlow / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10
Cash flows provided by operating activities:
Net income
2,567	2,554	1,841	1,688	2,146	1,611	1,017	679	1,397	1,247	1,518	2,346	1,557	1,352	1,366	958	101	-37	573	735	731	386	236	131	1,025	943	1,363	93	-2,241	-2,446	-4,048	-2,713	-2,140	-2,279	-1,917	-2,281	0	0	0
Adjustments to reconcile net income to net cash from operating activities:
Depreciation and amortization
326	315	321	321	318	332	339	348	359	373	396	393	389	382	357	351	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of operating lease right-of-use assets
456	462	457	453	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accretion of financing instruments and amortization of prepaid financing costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	235	0	0	0	-	-	-	-	905	0	0	0
Compensation expense on employee stock options
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	10	19	45	102	255	0	0	0
Financing costs for stock issued in connection with Convertible Note Payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Change in fair value of derivative liability
-	-	-	-	-	-	-	-494	-333	-371	177	427	576	798	429	64	124	-47	-488	-705	-662	-631	-266	21	-488	-304	-879	133	607	434	1,086	-9	-52	-11	-6	-2	0	0	0
Loss (income) from discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Depreciation and amortization
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	382	390	404	415	421	425	442	473	487	500	509	559	526	491	0	0	0
Accretion of financing instruments and amortization of prepaid financing costs
-	-	-	-	-	-	-	105	106	105	105	105	105	123	158	192	225	240	239	239	239	238	238	237	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Stock based compensation
0	0	0	-	-	-	-	14	24	31	49	49	44	40	26	31	128	121	113	104	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in deferred tax assets
-117	-22	-3	33	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Unrealized (gain) loss on investments
0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other, net
0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in deferred tax assets
-	-	-	-	-	-	-	-	0	0	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Impairment charge on investment in iBio, Inc.
-	-	-	-	-	-	-	358	287	287	119	36	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non cash charge of professional fees incurred in connection with Convertible Note Payable - CD Financial, LLC
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	197	0	0	0
Gain on disposal of fixed assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-6	-8	-2	7	-1	0	-66	-3	-31	0	0	0
Changes in operating assets and liabilities:
Accounts receivable
-734	313	-76	593	1,801	-36	750	-182	491	174	-1,093	884	-897	459	992	527	827	586	486	440	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accounts receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	151	371	420	1,625	1,113	627	508	703	-303	269	0	0	0
Inventories
-483	-2,246	292	1,077	1,993	3,477	2,557	96	675	232	-1,038	-111	1,049	808	1,993	1,978	943	267	-888	79	1,219	950	449	-733	-2,079	-694	1,395	1,140	-3,306	-2,617	-3,272	-2,106	1,518	2,111	-447	-408	0	0	0
Other current assets
-	-	-	73	60	53	34	7	-50	77	25	43	187	32	59	99	-104	-20	-18	42	61	68	45	-36	-4	-30	-31	-81	762	609	560	641	-56	-18	155	52	0	0	0
Operating lease right of use assets
-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Security deposits and other assets
-	-	0	-	-	-	0	-	-	0	0	-	-	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	-	-	-
Accounts payable
75	-2,915	-939	-329	1,162	1,617	2,323	7	197	-79	-1,107	-1,292	-973	-485	-800	727	227	580	-364	-488	923	897	774	-247	-1,614	-1,979	-783	-598	2,395	3,399	1,550	-352	-1,047	-361	481	1,106	0	0	0
Accrued expenses and other liabilities
-22	111	129	96	-23	-201	-227	-133	143	-92	90	-27	-90	253	-72	-326	-264	-143	-9	229	191	102	-79	187	-14	-248	-316	-428	0	0	0	-	0	0	0	-	0	0	0
Operating lease obligations
-458	-462	-458	-454	0	0	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by (used in) operating activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-594	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Net cash provided from operating activities - discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Net cash provided by (used in) operating activities
4,176	2,300	1,420	328	-474	-386	157	1,168	525	490	2,527	397	0	0	0	-	-	-	-	-	-	-	613	1,877	1,517	541	-543	-1,438	-1,643	-1,494	-1,114	-771	33	-1,009	123	392	0	0	0
Cash flows from investing activities:
Purchase of property and equipment
222	228	454	414	381	324	158	247	233	454	393	327	379	152	109	109	48	87	108	235	294	341	348	182	124	51	24	30	94	156	162	155	138	90	157	301	0	0	0
Proceeds from sale of machinery and equipment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	19	0	0	0	-	0	0	0	-	0	0	0
Cash contribution in AgroSport LLC
-	-	-	8	0	0	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in investing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Net cash used in investing activities - discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Net cash used in investing activities
-134	-226	-454	-422	-390	-330	-161	-242	-227	-450	-393	-327	0	0	0	-	-	-	-29	-156	-294	-341	-348	-182	-123	-50	-23	-11	-76	-131	-134	-143	-124	-83	-153	-269	0	0	0
Cash flows from financing activities:
Advances under revolving credit facility
48,553	49,864	49,773	48,937	46,615	44,390	41,371	41,164	41,054	42,018	42,826	45,385	45,997	45,184	45,169	41,166	38,976	37,154	36,754	36,993	35,848	33,684	32,243	32,341	33,505	35,156	35,077	34,714	0	0	0	-	-	-	-	-	-	-	-
Proceeds from issuance of note payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	40	0	0	0
Repayments of advances under revolving credit facility
51,274	50,999	49,672	47,997	44,787	42,853	40,577	40,945	40,441	41,232	43,806	44,919	46,507	47,146	44,503	41,418	39,172	36,617	37,116	36,652	34,857	32,489	32,006	32,763	34,126	34,773	33,687	32,848	0	0	0	-	-	-	-	-	-	-	-
Proceeds from Line of Credit Note
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	43	43	66	145	307	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Repayments under term note payables
3,371	3,303	3,321	3,023	620	620	599	959	984	983	1,001	829	829	835	845	620	662	646	628	616	539	540	834	834	834	834	541	496	0	0	0	-	-	-	-	-	-	-	-
Repayments under finance lease obligations
216	247	243	233	232	234	253	233	205	159	122	131	134	129	125	121	123	140	154	143	123	96	63	47	0	0	0	-	-	-	-	20	31	43	46	45	0	0	0
Net cash (used in) provided by financing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Net cash used in financing activities - discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Net cash (used in) provided by financing activities
-3,908	-2,052	-806	341	1,233	707	85	-830	-432	-52	-1,942	-333	0	0	0	-	-	-	-999	-111	640	847	-451	-1,299	-1,495	-480	830	1,359	1,355	1,302	533	334	-31	-43	-86	-45	0	0	0
Net increase in cash
134	22	160	247	369	-9	81	96	-134	-12	192	-263	-254	6	8	324	96	12	-210	-380	170	-87	-186	396	-101	11	264	-90	-364	-323	-715	-580	-122	-1,135	-116	78	0	0	0
Decrease (increase) in cash, discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Supplemental disclosures of cash flow information:
Interest paid
384	488	551	629	772	775	803	800	804	806	887	884	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	745	710	707	713	714	718	706	707	716	722	734	728	671	0	0	0	-	0	0	0	-	-	-	-
Income taxes paid
-	-	-	264	284	235	223	221	202	248	249	366	390	341	285	168	184	167	158	158	0	0	0	-	-	-	-	17	0	0	0	-	-	-	0	-	-	-	-
Accretion of discount on Convertible Note Payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	86	104	111	110	110	109	109	109	108	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of prepaid financing costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Financing on capitalized lease obligations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	317	252	182	14	185	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-